CA3044931A1 - Appareil et procede de filtration du sang a travers une membrane semi-permeable - Google Patents
Appareil et procede de filtration du sang a travers une membrane semi-permeable Download PDFInfo
- Publication number
- CA3044931A1 CA3044931A1 CA3044931A CA3044931A CA3044931A1 CA 3044931 A1 CA3044931 A1 CA 3044931A1 CA 3044931 A CA3044931 A CA 3044931A CA 3044931 A CA3044931 A CA 3044931A CA 3044931 A1 CA3044931 A1 CA 3044931A1
- Authority
- CA
- Canada
- Prior art keywords
- pump
- blood
- motor
- blood filtration
- semi
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 210000004369 blood Anatomy 0.000 title claims abstract description 403
- 239000008280 blood Substances 0.000 title claims abstract description 403
- 239000012528 membrane Substances 0.000 title claims abstract description 214
- 238000000034 method Methods 0.000 title claims abstract description 191
- 238000001914 filtration Methods 0.000 title claims abstract description 152
- 238000006073 displacement reaction Methods 0.000 claims abstract description 180
- 239000012530 fluid Substances 0.000 claims abstract description 151
- 238000011084 recovery Methods 0.000 claims abstract description 24
- 238000011144 upstream manufacturing Methods 0.000 claims abstract description 15
- 239000012466 permeate Substances 0.000 claims description 68
- 230000006870 function Effects 0.000 claims description 59
- 210000000748 cardiovascular system Anatomy 0.000 claims description 58
- 229940000032 cardiovascular system drug Drugs 0.000 claims description 58
- 238000011282 treatment Methods 0.000 claims description 46
- 230000002706 hydrostatic effect Effects 0.000 claims description 43
- 238000004140 cleaning Methods 0.000 claims description 30
- 230000008569 process Effects 0.000 claims description 30
- 230000006835 compression Effects 0.000 claims description 28
- 238000007906 compression Methods 0.000 claims description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 24
- 238000002615 hemofiltration Methods 0.000 claims description 23
- 239000011148 porous material Substances 0.000 claims description 22
- 230000009977 dual effect Effects 0.000 claims description 19
- 230000000694 effects Effects 0.000 claims description 18
- 238000013459 approach Methods 0.000 claims description 17
- 230000008878 coupling Effects 0.000 claims description 16
- 238000010168 coupling process Methods 0.000 claims description 16
- 238000005859 coupling reaction Methods 0.000 claims description 16
- 238000003860 storage Methods 0.000 claims description 16
- 230000002572 peristaltic effect Effects 0.000 claims description 13
- 238000011010 flushing procedure Methods 0.000 claims description 11
- 230000017531 blood circulation Effects 0.000 claims description 10
- 238000001631 haemodialysis Methods 0.000 claims description 9
- 230000000322 hemodialysis Effects 0.000 claims description 9
- 238000007789 sealing Methods 0.000 claims description 9
- 239000007788 liquid Substances 0.000 claims description 8
- 238000004519 manufacturing process Methods 0.000 claims description 8
- 238000012544 monitoring process Methods 0.000 claims description 8
- 238000005381 potential energy Methods 0.000 claims description 8
- 238000011001 backwashing Methods 0.000 claims description 7
- 238000001802 infusion Methods 0.000 claims description 7
- 230000033001 locomotion Effects 0.000 claims description 7
- 238000006467 substitution reaction Methods 0.000 claims description 7
- 230000001360 synchronised effect Effects 0.000 claims description 7
- 230000002829 reductive effect Effects 0.000 claims description 6
- 239000000654 additive Substances 0.000 claims description 5
- 230000000996 additive effect Effects 0.000 claims description 5
- 238000012545 processing Methods 0.000 claims description 5
- 230000007659 motor function Effects 0.000 claims description 4
- 230000010349 pulsation Effects 0.000 claims description 4
- 230000003252 repetitive effect Effects 0.000 claims description 4
- 238000009499 grossing Methods 0.000 claims description 3
- 210000002381 plasma Anatomy 0.000 claims description 3
- 238000007485 conventional hemodialysis Methods 0.000 claims description 2
- 238000012546 transfer Methods 0.000 claims description 2
- 239000002904 solvent Substances 0.000 claims 3
- 230000009885 systemic effect Effects 0.000 claims 2
- 238000006243 chemical reaction Methods 0.000 claims 1
- 230000002301 combined effect Effects 0.000 claims 1
- 238000000926 separation method Methods 0.000 abstract description 5
- 239000000706 filtrate Substances 0.000 abstract description 3
- 239000000306 component Substances 0.000 description 45
- 230000008901 benefit Effects 0.000 description 38
- 230000003466 anti-cipated effect Effects 0.000 description 27
- 238000005086 pumping Methods 0.000 description 26
- 238000013461 design Methods 0.000 description 25
- 230000001965 increasing effect Effects 0.000 description 18
- 230000002441 reversible effect Effects 0.000 description 16
- 239000000463 material Substances 0.000 description 14
- 238000005192 partition Methods 0.000 description 11
- 239000007789 gas Substances 0.000 description 10
- 239000002699 waste material Substances 0.000 description 10
- 238000004891 communication Methods 0.000 description 9
- 238000002156 mixing Methods 0.000 description 9
- 238000001223 reverse osmosis Methods 0.000 description 9
- 230000008859 change Effects 0.000 description 8
- 239000013535 sea water Substances 0.000 description 8
- 239000000243 solution Substances 0.000 description 8
- 210000002700 urine Anatomy 0.000 description 8
- 230000000670 limiting effect Effects 0.000 description 7
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- 239000000919 ceramic Substances 0.000 description 6
- 230000008030 elimination Effects 0.000 description 6
- 238000003379 elimination reaction Methods 0.000 description 6
- 230000036961 partial effect Effects 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- 210000004027 cell Anatomy 0.000 description 5
- 239000000470 constituent Substances 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 230000004907 flux Effects 0.000 description 5
- 210000002683 foot Anatomy 0.000 description 5
- 230000013011 mating Effects 0.000 description 5
- 238000000819 phase cycle Methods 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 230000009286 beneficial effect Effects 0.000 description 4
- 239000008358 core component Substances 0.000 description 4
- DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 4
- 230000003247 decreasing effect Effects 0.000 description 4
- 238000010612 desalination reaction Methods 0.000 description 4
- 238000011161 development Methods 0.000 description 4
- 230000018109 developmental process Effects 0.000 description 4
- 238000000502 dialysis Methods 0.000 description 4
- 210000003734 kidney Anatomy 0.000 description 4
- 238000004886 process control Methods 0.000 description 4
- 230000009467 reduction Effects 0.000 description 4
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 3
- 206010016717 Fistula Diseases 0.000 description 3
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 3
- 239000003146 anticoagulant agent Substances 0.000 description 3
- 229940127219 anticoagulant drug Drugs 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 238000000576 coating method Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 230000003890 fistula Effects 0.000 description 3
- 229910021389 graphene Inorganic materials 0.000 description 3
- 238000003780 insertion Methods 0.000 description 3
- 230000037431 insertion Effects 0.000 description 3
- 230000003993 interaction Effects 0.000 description 3
- 208000017169 kidney disease Diseases 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 230000003204 osmotic effect Effects 0.000 description 3
- 229920000642 polymer Polymers 0.000 description 3
- 230000007704 transition Effects 0.000 description 3
- 108091023037 Aptamer Proteins 0.000 description 2
- 206010028980 Neoplasm Diseases 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- 208000001647 Renal Insufficiency Diseases 0.000 description 2
- 108010046334 Urease Proteins 0.000 description 2
- 238000011256 aggressive treatment Methods 0.000 description 2
- 210000004712 air sac Anatomy 0.000 description 2
- 210000003423 ankle Anatomy 0.000 description 2
- 230000000712 assembly Effects 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 230000005540 biological transmission Effects 0.000 description 2
- 230000000903 blocking effect Effects 0.000 description 2
- 230000036772 blood pressure Effects 0.000 description 2
- 230000036770 blood supply Effects 0.000 description 2
- 230000037396 body weight Effects 0.000 description 2
- 230000015556 catabolic process Effects 0.000 description 2
- 238000010276 construction Methods 0.000 description 2
- 238000011109 contamination Methods 0.000 description 2
- 230000008602 contraction Effects 0.000 description 2
- 229940109239 creatinine Drugs 0.000 description 2
- 230000001351 cycling effect Effects 0.000 description 2
- 230000002526 effect on cardiovascular system Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 238000011049 filling Methods 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 239000008240 homogeneous mixture Substances 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 201000006370 kidney failure Diseases 0.000 description 2
- 210000004324 lymphatic system Anatomy 0.000 description 2
- 238000005457 optimization Methods 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 238000001228 spectrum Methods 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 238000010146 3D printing Methods 0.000 description 1
- 208000003870 Drug Overdose Diseases 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 206010053159 Organ failure Diseases 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 229920000316 Poly pentamethylene hexamethylene dicarbamate Polymers 0.000 description 1
- 239000011358 absorbing material Substances 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 238000002617 apheresis Methods 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 210000000601 blood cell Anatomy 0.000 description 1
- 239000012503 blood component Substances 0.000 description 1
- 235000012206 bottled water Nutrition 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 238000002512 chemotherapy Methods 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000010924 continuous production Methods 0.000 description 1
- 230000008021 deposition Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 230000003467 diminishing effect Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 231100000725 drug overdose Toxicity 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 238000009434 installation Methods 0.000 description 1
- 238000005342 ion exchange Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 210000002414 leg Anatomy 0.000 description 1
- 230000001926 lymphatic effect Effects 0.000 description 1
- 238000005374 membrane filtration Methods 0.000 description 1
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 description 1
- 229910052753 mercury Inorganic materials 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 239000003607 modifier Substances 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 230000010355 oscillation Effects 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000037074 physically active Effects 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 229920000515 polycarbonate Polymers 0.000 description 1
- 239000004417 polycarbonate Substances 0.000 description 1
- 229920005597 polymer membrane Polymers 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- 230000000750 progressive effect Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000005855 radiation Effects 0.000 description 1
- 239000012925 reference material Substances 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000002787 reinforcement Effects 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000012827 research and development Methods 0.000 description 1
- 239000012858 resilient material Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000005096 rolling process Methods 0.000 description 1
- 238000012163 sequencing technique Methods 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 238000000108 ultra-filtration Methods 0.000 description 1
- 210000000689 upper leg Anatomy 0.000 description 1
- 238000013022 venting Methods 0.000 description 1
- 238000012800 visualization Methods 0.000 description 1
- 230000036642 wellbeing Effects 0.000 description 1
- 230000003245 working effect Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3403—Regulation parameters
- A61M1/341—Regulation parameters by measuring the filtrate rate or volume
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/34—Filtering material out of the blood by passing it through a membrane, i.e. hemofiltration or diafiltration
- A61M1/3403—Regulation parameters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M1/00—Suction or pumping devices for medical purposes; Devices for carrying-off, for treatment of, or for carrying-over, body-liquids; Drainage systems
- A61M1/36—Other treatment of blood in a by-pass of the natural circulatory system, e.g. temperature adaptation, irradiation ; Extra-corporeal blood circuits
- A61M1/3621—Extra-corporeal blood circuits
- A61M1/3639—Blood pressure control, pressure transducers specially adapted therefor
Landscapes
- Health & Medical Sciences (AREA)
- Heart & Thoracic Surgery (AREA)
- Vascular Medicine (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Hematology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Cardiology (AREA)
- External Artificial Organs (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CA3,018,662 | 2018-09-27 | ||
| CA3018662A CA3018662A1 (fr) | 2018-09-27 | 2018-09-27 | Appareil et procede de filtration du sang a travers une membrane semi-permeable |
| CA3,027,251 | 2018-12-13 | ||
| CA3027251A CA3027251A1 (fr) | 2018-09-27 | 2018-12-13 | Appareil et procede de filtration du sang a travers une membrane semi-permeable |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3044931A1 true CA3044931A1 (fr) | 2020-03-27 |
Family
ID=69948333
Family Applications (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3018662A Abandoned CA3018662A1 (fr) | 2018-09-27 | 2018-09-27 | Appareil et procede de filtration du sang a travers une membrane semi-permeable |
| CA3027251A Abandoned CA3027251A1 (fr) | 2018-09-27 | 2018-12-13 | Appareil et procede de filtration du sang a travers une membrane semi-permeable |
| CA3044931A Abandoned CA3044931A1 (fr) | 2018-09-27 | 2019-06-03 | Appareil et procede de filtration du sang a travers une membrane semi-permeable |
Family Applications Before (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3018662A Abandoned CA3018662A1 (fr) | 2018-09-27 | 2018-09-27 | Appareil et procede de filtration du sang a travers une membrane semi-permeable |
| CA3027251A Abandoned CA3027251A1 (fr) | 2018-09-27 | 2018-12-13 | Appareil et procede de filtration du sang a travers une membrane semi-permeable |
Country Status (1)
| Country | Link |
|---|---|
| CA (3) | CA3018662A1 (fr) |
-
2018
- 2018-09-27 CA CA3018662A patent/CA3018662A1/fr not_active Abandoned
- 2018-12-13 CA CA3027251A patent/CA3027251A1/fr not_active Abandoned
-
2019
- 2019-06-03 CA CA3044931A patent/CA3044931A1/fr not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CA3027251A1 (fr) | 2020-03-27 |
| CA3018662A1 (fr) | 2020-03-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1471954B1 (fr) | Dispositif de thérapie de remplacement rénal continu portable | |
| US7976709B2 (en) | System and method for regeneration of a fluid | |
| WO2009099714A1 (fr) | Système de dialyse avec recyclage du fluide de dialyse | |
| JP2009254918A5 (fr) | ||
| US20160375190A1 (en) | Peritoneal dialysis systems and methods | |
| CN108778364A (zh) | 在透析治疗系统中的流体回路中产生快速变化的压力幅度的方法和系统 | |
| US9925322B2 (en) | Dialysate supply device and blood dialyzing apparatus having the same | |
| CA3044931A1 (fr) | Appareil et procede de filtration du sang a travers une membrane semi-permeable | |
| WO2021056091A1 (fr) | Appareil et procédé de filtration sanguine à base de membrane semi-perméable | |
| US11185620B2 (en) | Fluid pumping device and blood purifying apparatus having the same | |
| CA3073544A1 (fr) | Hemofiltre a alimentation autonome comportant une intensification de pression hydrostatique autoreglable | |
| US20230270925A1 (en) | Blood dialyzing apparatus and method | |
| EP3815724B1 (fr) | Appareil de traitement du sang | |
| JP7350848B2 (ja) | 循環血液量過多症を治療する埋め込み型装置 | |
| KR102102562B1 (ko) | 투석용액 이송장치 및 이를 갖는 혈액정화장치 | |
| JP7374510B2 (ja) | 血液処理のための装置、消耗品、方法及びシステム | |
| CN114286703B (zh) | 用于医用流体泵送系统的多腔管组件 | |
| US20240416018A1 (en) | Blood dialyzing apparatus and method | |
| WO2025008740A1 (fr) | Appareil et procédé de dialyse sanguine | |
| US20230025881A1 (en) | System for ultrafiltration of blood | |
| Lee | Push/pull based renal replacement treatments | |
| US20200353147A1 (en) | Fluid pumping device and blood purifying apparatus having the same | |
| Lee et al. | Portable and Wearable Dialysis Devices for the Treatment of Patients | |
| KR101638233B1 (ko) | 투석액 공급장치 및 이를 갖는 혈액투석장치 | |
| CN115361979A (zh) | 优化透析器性能 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FZDE | Discontinued |
Effective date: 20221205 |
|
| FZDE | Discontinued |
Effective date: 20221205 |